Share these talks and lectures with your colleagues
Invite colleaguesWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login
or review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Why IBD?
- Increasing incidence and prevalence of IBD
- Genetic testing
- IBD-specific serologic immune markers
- Video capsule endoscopy
- Ulcerations in endoscopy
- CT enterography
- MR enteroclysis
- Goals of therapy
- Therapeutic pyramid
- Site of oral mesalamine release
- Anti-TNF “engineered” antibodies
- Anti-adhesion mechanism of action
- SONIC: Steroid free CD remission at week 26
- Clinical response for UC at weeks 8 & 30
- Update on infliximab: post-op
- Anti-TNF: update on side effect profile
- Adverse events with common regimens for CD
- “Can I stop my medicine?”
- Newer biologics
- Other agents under investigation
- New form of steroid
- Miscellaneous agents
- CAM and IBD
- Probiotics and CD
- Probiotics and UC
- Prebiotics and UC
- Another alternative agent
- Herbal supplements
- Summary points
Topics Covered
- Increasing incidence and prevalence of IBD
- Genetic testing & immune markers
- Video capsule endoscopy & imaging
- Therapy
- Combination therapy
- Newer biologics
- Complementary & alternative medicine
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Kane, S. (2016, November 30). Inflammatory bowel disease: what the internist should know [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved January 20, 2021, from https://hstalks.com/bs/1907/.Publication History
Financial Disclosures
- Prof. Sunanda Kane, Consultant: Abbot, Elam, Shire, UCB / Grant/Research Support (Principal Investigator): Elam, Shire.
Inflammatory bowel disease: what the internist should know
Other Talks in the Category: Diseases, Disorders & Treatments
Transcript
0:00
This is Dr. Sunanda Kane,
Professor of Medicine
at Mayo Clinic College of Medicine
in Rochester, Minnesota.
And we're going to be talking
about Inflammatory Bowel Disease
and What the Internist Should Know.
0:12
Why should we be talking
about inflammatory bowel disease
to the internist?
Well, from 1998 to 2005,
there was a 450% increase in visits
to primary care by Crohn's patients
and 350% by ulcerative colitis patients.
In that timeframe,
there has been a decrease
in the use of steroids
and hospitalizations
for Crohn's patients as well as
for ulcerative colitis patients.
This means that primary care physicians
are doing a very good job
of treating these patients
and keeping them off of steroids
and keeping them out of the hospital.
0:48
There is an increasing incidence
and prevalence
of inflammatory bowel disease as well.
A systematic review with information
dating back to the 1920s,
showed a time trend analysis
where 75% of Crohn's studies
and 60% of ulcerative colitis studies
had an increasing incidence
of statistical significance.
The highest annual incidence
of ulcerative colitis
at 24 per 100,000 person years
is in Europe
and actually there is an incidence
now for Asia at 6.3 per 100,000.
The highest annual incidence
for Crohn's disease
is about 13 people per 100,000
in Europe and 5 now in Asia.
1:29
I often get asked about genetic testing.
Is inflammatory bowel disease
a genetic disorder?
Well, there are
now greater than 100 genes
associated with Crohn's disease
that have been identified.
These are candidate genes
not causative genes.
And the genetic information we have
has come from families with IBD,
not single cases.
So while genetic testing
is commercially available,
it needs to be
in conjunction with counseling
as there is not one single gene
that explains all of Crohn's disease
and certainly no single gene
explains ulcerative colitis.